Search

To investigate the potential role of allelopathy in plant interference and in the successful invasion of alien species Solidago canadensis, aqueous and ethanolic extracts from rhizomes, stems and leaves of S. canadensis were prepared and used as treatment solutions to assess their effects on seed germination and seedling growth in four target species, mulberry (Morus alba); morning glory (Pharbitis nil), wheat (Triticum aestivum) and rape (Brassica campestris). Reduction and/or growth in germination and growth of the target plant species in the presence of both aqueous and ethanolic extracts at different concentrations indicated that the responses were species-specific and concentration-dependent. Generally, ethanolic extracts (especially from leaves) imposed stronger effects on both seed germination and seedling growth. Extracts with lower concentration at 0.001 g/ml dw could stimulate the seedling growth of rape and morning glory, whereas extracts at any given concentrations have inhibitory effects on wheat and mulberry. It is suggested that the aqueous and ethanolic extracts of all the three parts of S. canadensis have significant allelopathic effects. Although both inhibition and stimulation occurred in the germination and growth of the target species, extracts with higher concentrations definitely inhibit seed germination and seedling growth of all target plants. We suggest that allelopathy plays a more important role than other mechanisms do in the out-competition of S. canadensis over other plants, and make it invasive in new habitats. [ABSTRACT FROM AUTHOR]

Abstract: The potential use of hydroxypropyl-β-cyclodextrin (HP-βCD) in the solubilization and stabilization of prostaglandin E1 (PGE1) was investigated. The solubility and chemical stability of PGE1 were significantly improved upon complexation with HP-βCD. The nasal delivery of PGE1 from the complex formulation was also studied in Wistar rats and compared with intravenous administration. PGE1 complex after nasal administration caused a rapid decrease of blood pressure and exhibited an obvious dose-efficacy relationship, showing results nearly similar to those obtained for intravenous route. The time to reach the peak effect (T max) was approximately 3–4min. Except T max, other pharmacodynamic parameter values such as the maximal percent of blood pressure decrease (E max, %), the lasting time of effect (T d), and the area under the curve (AUC, blood pressure decrease % min) were increased with increasing the administered doses. The E max, T d, and in particular AUC values between doses were significantly different (P <0.01), but T max between doses were not significantly different (P <0.05). The AUC values per unit dose of PGE1 for nasal administration, however, were smaller than those for intravenous route, probably due to the incomplete absorption of nasally administered PGE1. Besides, the in vitro effect of the PGE1 complex on nasal mucociliary movement was also investigated with a toad palate model. The PGE1 complex formulation exerted only minor effect on nasal mucociliary movement. These results indicate that the PGE1–HP-βCD complex formulation for nasal delivery is a very promising preparation with advantages such as rapid and effective absorption, good chemical stability, ease of administration, and minor nasal ciliotoxicity. [Copyright &y& Elsevier]

The pharmacodynamics of prostaglandin E1 (PGE1) administered by different routes to rats was investigated in this paper. The hypotensive effect of PGE, was used as an index of drug efficacy, pharmacodynamic parameters such as time to reach peak effect (Tmax), maximal percentage of blood pressure decrease (Emax, %), duration of effect (Td), and the area under the blood pressure decrease percent-time curves (AUC, % x min) were determined after PGE1 given to rats intranasally, sublingually, intraperitoneally (ip), and intramuscularly (im), separately, and compared with those obtained from intravenous (iv) administration. Similar to iv route, the pharmacodynamic parameters of PGE1 from the other administration routes, Emax, Td and in particular AUC values were all increased with increasing doses, showing dose-efficacy relationship. Tmax was found to be approximately 3-4 min for nasal route, 3-8 min for im, 6-8 min for ip and 12-30 min for sublingual route, separately. Thus, the order of magnitude of absorption rate of the drug was as follows: nasal approximately = im > ip > sublingual. If the pharmacological bioavailability (PF) for each administration route was used as a tentative measure of drug absorption extent, the order of magnitude of absolute bioavailability appeared as follows: nasal > im approximately = ip > sublingual. Furthermore, the interindividual difference was found to be larger for im and ip route than that for nasal and sublingual route. These results indicate nasal and sublingual routes are two promising routes for the systemic delivery of PGE1 in clinical applications.

Ac and Ds insertions among the genomic DNAs of hybrids of Ac x Ds lines were screened by PCR. The genomic DNAs, which were proved to harbour both Ac and Ds, were used as templates in TAIL-PCR to clone the Ds flanking sequences. The cloned specific fragments were sequenced, and the sequenced Ds flanking sequences were used as query sequences to perform on-line sequence comparing analysis against GenBank by employing BLAST program of NCBI. The information about the chromosome location of Ds-inserted genes, or genes immediately downstream of the inserted sites, and their functional innotations were achieved. Based on the analysis from the cloned 93 Ds-flanking sequences, it was found that 21 hybrid plants had Ds insertions in genic regions, whereas the remaining 72 samples's intergenic regions were inserted by Ds element. Moreover, among the 72 regions, 12 were inserted immediately upstream (within 3 kb) of specific genes. Also, the strategies to improve the performance in cloning the Ds flanking sequences and in screening the Ac/Ds lines were emphasized.

Aim: To investigate the complexation of prostaglandin E1 (PGE1) with hydroxylpropyl-beta-cyclodextrin (HP-beta-CD) in aqueous solutions, inclusion molar ratio of the host and guest molecules and change of thermodynamic parameters during the complexation process., Methods: The measurements of the complexation mechanism, inclusion molar ratio of the host and guest molecules and change of thermodynamic parameters were carried out by the following methods separately: phase solubility method, UV absorption spectroscopy, circular dichroism spectroscopy, equimolar series method and thermodynamic method, respectively., Results: That all the phase solubility diagrams showed a typical AL-type in various pH buffered solutions, suggested the formation of a soluble complex of 1:1 molar ratio. Both UV absorption spectroscopy and circular dichroism spectroscopy confirmed that the significant interaction between the host and guest molecules was probably due to the inclusion of chromophore moiety of PGE1 molecule into the hydrophobic cavity of HP-beta-CD molecule. The change in the thermodynamic parameters suggested that the complexation could proceed spontaneously along with the release of heat and the decrease of entropy., Conclusion: An 1:1 molar ratio inclusion complex of PGE1 with HP-beta-CD could be formed spontaneously and, hence, the solubility of PGE1 in aqueous solution increased. Appropriate temperature and suitable media pH probably favor the progress of complexation procedure.